Currently, insiders own just 1.51% of Exact Sciences Corp (EXAS)’s shares, while financial institutions hold 98.07%. Notable insider trades include Condella Sarah, EVP, Human Resources at Exact ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant advancements in the development of a ...

On Wednesday, Exact Sciences Corp (EXAS) stock saw a decline, ending the day at $54.72 which represents a decrease of $-16.79 or -23.48% from the prior close of $71.51. The stock opened at $55.7 and ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...

Start teaching within months! Join a free virtual session on Tuesday, Nov. 12 at 4:30 p.m. CST. The University of Houston's Human Development & Family Sciences program provides a broad study of the ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Exact Sciences (NASDAQ ... they are also human and can only forecast their beliefs to ...

Learn about the geoscience data and knowledge that are available to those working to manage Canada’s landmass and develop its natural resources responsibly.

--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present modeling data evaluating the simulated ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present modeling data evaluating the simulated benefit and burden ...

October 27, 2024--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present modeling data ...